Simcere Pharmaceutical Group. (SCR) Earnings
|
Expand Research on SCR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -23.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/10  |
 |
Q310 | $0.08 | N/A | N/A | N/A | N/A | N/A |  | | Details |
| 3/7/13 |
|
Q412 | -$0.06 | $0.00 | -$0.06 | $86.7M | $88.06M | N/A | | | Details |
| 3/7/12 |
|
Q411 | $0.12 | $0.10 | +$0.02 | $81.2M | $86.35M | N/A | | | Details |
| 5/10/11 |
|
Q111 | $0.08 | $0.11 | -$0.03 | $73.6M | $79.37M | N/A | | | Details |
| 5/9/13 |
|
Q113 | RMB0.56 | N/A | N/A | RMB528.73M | RMB487.61M | N/A | | | Details |
| 11/15/12 |
|
Q312 | $0.07 | $0.07 | $0.00 | $83.8M | $85.72M | N/A | | | Details |
| 11/14/13 | Q313 | $0.51 | N/A | N/A | $68.8M | $78.5M | N/A | | | Details | |
| 4/13/21 |
|
Q221 | -Cdn$0.45 | N/A | N/A | Cdn$5.59M | Cdn$6.65M | N/A | | | Details |
